![Acurx Pharmaceuticals Inc](/common/images/company/N_ACXP.png)
Acurx Pharmaceuticals Inc (ACXP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -192.349 | -106.871 | -170.643 |
Return on Equity (%) | -205.431 | -122.616 | -243.332 |
Return on Invested Capital (%) | -206.511 | -122.616 | -243.332 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 1.215 | 0.629 | 0.339 |
Earnings Per Share | -1.248 | -1.04 | -1.059 |
Cash Per Share | 1.269 | 0.784 | 0.543 |
Working Capital Per Share | 1.215 | 0.629 | 0.339 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -1.248 | -1.04 | -1.059 |
EBITDA Per Share | -1.248 | -1.04 | -1.059 |
Free Cash Flow Per Share | -1.248 | -1.04 | -1.059 |
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | 10,22M | 11,63M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||||||
Actions en circulation | 11,63M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 12,53M |
Ratio cours/bénéfice | -0,86 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,67 |
Ratio prix/valeur comptable | 2,68 |
Rendement de dividende | - |
Actions en circulation | 16,89M |
Volume moyen (1 semaine) | 72,18k |
Volume moyen (1 mois) | 111,93k |
Variation sur 52 semaines | -77,10% |
Plus haut sur 52 semaines | 3,35 |
Plus bas sur 52 semaines | 0,68 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales